National Committee on Vital and Health Statistics: Meeting, 61145-61146 [05-20990]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 202 / Thursday, October 20, 2005 / Notices
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Muscular Dystrophy Coordinating
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
inform the Contact Person listed below
in advance of the meeting.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Transplantation of
Hepatic Cells.
Date: November 16, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Carol J. Goter-Robinson,
PhD., Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 748, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7791,
goterrobinsonc@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Small Clinical
Grants in Digestive Diseases and Nutrition.
Date: December 7, 2005.
Time: 8 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Maria E. Davila-Bloom,
PhD., Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 758, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7637, davilabloomm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Name of Committee: Muscular Dystrophy
Coordinating Committee.
Date: November 9, 2005.
Time: 8 a.m. to 3:30 p.m.
Agenda: Topics proposed for discussion:
(1) Activities and recent initiatives; (2)
progress of the Senator Paul Wellstone
Muscular Dystrophy Cooperative Research
Centers; (3) recommendations of the MDCC
Scientific Working Group; (4) efforts for
translational research in muscular dystrophy;
and (5) advances in the rare/understudied
muscular dystrophies.
Place: Embassy Suites Hotel at the Chevy
Chase Pavilion, 4300 Military Road, NW.,
Washington, DC 20015, (202) 362–9300.
Contact Person: John D. Porter, PhD,
Executive Secretary, Muscular Dystrophy
Coordinating Committee, National Institute
of Neurological Disorders and Stroke, NIH,
6001 Executive Boulevard, NSC 2172,
Bethesda, MD 20892, (301) 496–1917,
porterjo@ninds.nih.gov.
Any interested person may file written
comments with the committee by forwarding
their statement to the Contact Person listed
on this notice. The statement should include
the name, address, telephone number and
when applicable, the business or professional
affiliation of the interested person.
Information is also available on the MDCC
Web site: https://www.ninds.nih.gov/research/
muscular_dystrophy/
coordinating_committee, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: October 11, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–21021 Filed 10–19–05; 8:45 am]
Dated: October 11, 2005.
Anthony M. Coehlo, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–21023 Filed 10–19–05; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Committee on Vital and Health
Statistics: Meeting
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to the Federal Advisory
Committee Act, the Department of
Health and Human Services (HHS)
announces the following advisory
committee meeting.
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
VerDate Aug<31>2005
16:14 Oct 19, 2005
Jkt 208001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
61145
Name: National Committee on Vital
and Health Statistics (NCVHS)
Time and Date: November 16, 2005, 9
a.m.–3:30 p.m. November 17, 2005, 10
a.m.–2 p.m.
Place: Hubert H. Humphrey Building,
200 Independence Avenue SW., Room
705A, Washington, DC 20201.
Status: Open.
Purpose: At this meeting the
Committee will hear presentations and
hold discussions on several health data
policy topics. On the morning of the
first day the Committee will hear
updates and status reports from the
Department on various topics including
activities of the HHS Data Council, and
updates on HIPAA implementation
including data standards, the EPrescribing Final Rule, Privacy Rule
compliance, an the Notice of Proposed
Rulemaking for health claims
attachments. They will also hear an
update on activities of the Office of the
National Coordinator for Health
Information Technology. In the
afternoon the Committee will be
updated on the status of activities being
conducted by the Subcommittee on
Privacy and Confidentiality on the
National health Information Network,
and hear a presentation on secondary
uses of clinical data.
On the morning of the second day the
Committee will hear a presentation on
health statistics and the national health
information infrastructure and a
discussion of data release and
confidentiality issues led by a
representative of the National Center for
Health Statistics’ Board of Scientific
Counselors. In the afternoon, there will
be reports from the Subcommittees and
a discussion of agendas for future
Committee meetings.
The times shown above are for the full
Committee meeting. Subcommittee
breakout sessions are scheduled for late
in the afternoon of the first day and in
the morning prior to the full Committee
meeting on the second day. Agendas for
these breakout sessions will be posted
on the NCVHS Web site (URL below)
when available.
Contact Person for More Information:
Substantive program information as
well as summaries of meetings and a
roster of committee members may be
obtained from Marjorie S. Greenberg,
Executive Secretary, NCVHS, National
Center for Health Statistics, Centers for
Disease Control and Prevention, 3311
Toledo Road, Room 2402, Hyattsville,
Maryland 20782, telephone (301) 458–
4245. Information also is available on
the NCVHS home page of the HHS Web
site: https://www.ncvhs.hhs.gov/, where
further information including an agenda
will be posted when available.
E:\FR\FM\20OCN1.SGM
20OCN1
61146
Federal Register / Vol. 70, No. 202 / Thursday, October 20, 2005 / Notices
Should you require reasonable
accommodation, please contact the CDC
Office of Equal Employment
Opportunity on (301) 458–4EEO (4336)
as soon as possible.
Dated: October 14, 2005.
James Scanlon,
Deputy Assistant Secretary for Planning and
Evaluation (OSDP), Office of the Assistant
Secretary for Planning and Evaluation.
[FR Doc. 05–20990 Filed 10–19–05; 8:45am]
BILLING CODE 4151–05–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Statement of Organization, Functions,
and Delegations of Authority
Part N, National Institutes of Health,
of the Statement of Organization,
Functions, and Delegations of Authority
for the Department of Health and
Human Services (HHS) (40 FR 22859,
May 27, 1975, as amended most recently
at 69 FR 64081, November 3, 2004, and
redesignated from Part HN as Part N at
60 FR 56606, November 9, 1995), is
amended as set forth below to reflect the
consolidation of acquisitions activities
at the National Institutes of Health
(NIH). This change is designed to
strengthen NIH’s administrative
structure in order to meet the goals and
mission of NIH. The proposed
reorganization is consistent with the
agreement reached between HHS and
NIH on consolidation of the acquisitions
function.
Section N–B, Organization and
Functions, under the heading National
Cancer Institute (NC, formerly HNC),
Office of the Director, Office of
Management, is amended as follows:
Office of Acquisitions (NC17B,
formerly HNC17B). (1) Manages and
conducts a comprehensive program of
all research and development
contracting, non-research and
development contracting, station
support contracting, commercial item
acquisitions using simplified
acquisition procedures, GSA Federal
Supply Schedule acquisitions and
simplified acquisitions for customer
institutes and centers (IC). (2) Provides
advice and assistance regarding all
phases of the acquisition cycle from
planning to closeout with the purpose of
accomplishing all acquisitions needed
for the scientific mission and all related
acquisitions required by its customers.
Treatment and Biology Sciences
Branch (NC17B2, formerly HNC17B2).
(1) Participates in planning research/
research support contract programs for
VerDate Aug<31>2005
16:14 Oct 19, 2005
Jkt 208001
the Division of Cancer Treatment and
Diagnosis, the Division of Cancer
Biology, and the Center for Cancer
Research; (2) advertises proposed
acquisitions; (3) assists in reviewing
contract proposals submitted in
response to Requests for Proposals
(RFPs); (4) negotiates and makes
contract awards; and (5) manages postaward business aspects of contracts, and
assists Project Officers in managing
scientific aspects of those contracts.
Purchasing and Support Acquisition
Branch (NC17B3, formerly HNC17B3).
(1) Participates in the planning for nonresearch acquisitions for the NCI; (2)
advertises, solicits proposals, assists in
review, negotiations, and in making
awards; (3) manages all business related
aspects of the awards during the postaward phase, and assists Project Officers
as necessary in their oversight and
management of those awards.
Prevention, Control, and Population
Sciences Branch (NC17B4, formerly
HNC17B4). (1) Participates in planning
research/research support contract
programs for the Division of Cancer
Prevention and the Division of Cancer
Control and Population Sciences; (2)
advertises proposed acquisitions; (3)
assists in reviewing contract proposals
submitted in response to Requests for
Proposals (RFPs); (4) negotiates and
makes contract awards; and (5) manages
post-award business aspects of
contracts, and assists Project Officers in
managing scientific aspects of those
contracts.
Epidemiology and Support Branch
(NC17B5, formerly HNC17B5). (1)
Participates in planning research/
research support contract programs for
the Division of Cancer Epidemiology
and Genetics and the Office of the
Director, NCI; (2) advertises proposed
acquisitions; (3) assists in reviewing
contract proposals submitted in
response to Requests for Proposals
(RFPs); (4) negotiates and makes
contract awards; and (5) manages postaward business aspects of contracts, and
assists Project Officers in managing
scientific aspects of those contracts.
FCRDC Management Operations and
Support Branch (NC17B6, formerly
HNC17B6). (1) Participates in planning
the research and research support
contract programs for the National
Cancer Institute—Frederick Cancer
Research and Development Center
(NCI–FCRDC; also, Center); (2) directs
the administrative and business
operations of the Center; (3) administers
a system of research contracts for the
management and operation of the
Center; (4) develops acquisition plans
and conducts recompetitions,
evaluations, and awards of the contracts
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
that support the operation of the Center;
(5) manages the utilization of space, the
maintenance of all buildings and
grounds, and the use and provision of
other resources and services needed by
the research programs at the FCRDC;
and, (6) assists the Office of the Director,
NCI, in managing the scientific aspects
of those contracts.
Section N–B, Organization and
Functions, under the heading National
Heart, Lung, and Blood Institute (NH,
formerly HNH), Division of Extramural
Affairs, is amended as follows:
Office of Acquisitions (NH54, formerly
HNH54). (1) Manages and conducts a
comprehensive program of all research
and development contracting, nonresearch and development contracting,
station support contracting, commercial
item acquisitions using simplified
acquisition procedures, GSA Federal
Supply Schedule acquisitions and
simplified acquisitions for customer ICs.
(2) Provides advice and assistance
regarding all phases of the acquisition
cycle from planning to closeout with the
purpose of accomplishing all
acquisitions needed for the scientific
mission and all related acquisitions
required by its customers.
Heart, Lung, and Vascular Diseases
Branch (NH542, formerly HNH542). (1)
Plans, manages and carries out research
and development contracting activities
in support of the National Heart, Lung,
and Blood Institute (NHLBI) and its
Customer ICs’ scientific missions,
including the solicitation, negotiation,
coordination, awarding, and monitoring
of all actions; (2) works with program
staff and provides advice and guidance
to support their research activities in the
most effective and efficient manner; (3)
develops guidelines, procedures, and
internal controls to ensure proper and
continuing implementation of NIH and
other applicable policies, laws and
regulations; (4) coordinates with other
Branches within the NHLBI Office of
Acquisitions and elsewhere at NIH to
develop new approaches and identify
and implement best practices; and (5)
provides liaison support and
representation to the greater NIH
acquisition community.
Blood Diseases and Resources/NIAMS
Branch (NH544, formerly HNH544). (1)
Plans, manages and carries out research
and development contracting activities
in support of the NHLBI and its
Customer ICs’ scientific missions,
including the solicitation, negotiation,
coordination, awarding, and monitoring
of all actions; (2) works with program
staff and provides advice and guidance
to support their research activities in the
most effective and efficient manner; (3)
develops guidelines, procedures, and
E:\FR\FM\20OCN1.SGM
20OCN1
]]>Agencies
[Federal Register Volume 70, Number 202 (Thursday, October 20, 2005)]
[Notices]
[Pages 61145-61146]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-20990]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Committee on Vital and Health Statistics: Meeting
Pursuant to the Federal Advisory Committee Act, the Department of
Health and Human Services (HHS) announces the following advisory
committee meeting.
Name: National Committee on Vital and Health Statistics (NCVHS)
Time and Date: November 16, 2005, 9 a.m.-3:30 p.m. November 17,
2005, 10 a.m.-2 p.m.
Place: Hubert H. Humphrey Building, 200 Independence Avenue SW.,
Room 705A, Washington, DC 20201.
Status: Open.
Purpose: At this meeting the Committee will hear presentations and
hold discussions on several health data policy topics. On the morning
of the first day the Committee will hear updates and status reports
from the Department on various topics including activities of the HHS
Data Council, and updates on HIPAA implementation including data
standards, the E-Prescribing Final Rule, Privacy Rule compliance, an
the Notice of Proposed Rulemaking for health claims attachments. They
will also hear an update on activities of the Office of the National
Coordinator for Health Information Technology. In the afternoon the
Committee will be updated on the status of activities being conducted
by the Subcommittee on Privacy and Confidentiality on the National
health Information Network, and hear a presentation on secondary uses
of clinical data.
On the morning of the second day the Committee will hear a
presentation on health statistics and the national health information
infrastructure and a discussion of data release and confidentiality
issues led by a representative of the National Center for Health
Statistics' Board of Scientific Counselors. In the afternoon, there
will be reports from the Subcommittees and a discussion of agendas for
future Committee meetings.
The times shown above are for the full Committee meeting.
Subcommittee breakout sessions are scheduled for late in the afternoon
of the first day and in the morning prior to the full Committee meeting
on the second day. Agendas for these breakout sessions will be posted
on the NCVHS Web site (URL below) when available.
Contact Person for More Information: Substantive program
information as well as summaries of meetings and a roster of committee
members may be obtained from Marjorie S. Greenberg, Executive
Secretary, NCVHS, National Center for Health Statistics, Centers for
Disease Control and Prevention, 3311 Toledo Road, Room 2402,
Hyattsville, Maryland 20782, telephone (301) 458-4245. Information also
is available on the NCVHS home page of the HHS Web site: https://
www.ncvhs.hhs.gov/, where further information including an agenda will
be posted when available.
[[Page 61146]]
Should you require reasonable accommodation, please contact the CDC
Office of Equal Employment Opportunity on (301) 458-4EEO (4336) as soon
as possible.
Dated: October 14, 2005.
James Scanlon,
Deputy Assistant Secretary for Planning and Evaluation (OSDP), Office
of the Assistant Secretary for Planning and Evaluation.
[FR Doc. 05-20990 Filed 10-19-05; 8:45am]
BILLING CODE 4151-05-M
